Cardioprotective strategies against doxorubicin-induced cardiotoxicity: A review from standard therapies to emerging mitochondrial transplantation
Authors:
Top Cited Papers
Open Access
- 3 July 2025
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 189, 118315
Abstract
No abstract availableKeywords
This publication has 130 references indexed in Scilit:
- Mitochondrial Amount Determines Doxorubicin‐Induced Cardiotoxicity in CardiomyocytesAdvanced Science, 2025
- ACEI/ARB and beta-blocker therapies for preventing cardiotoxicity of antineoplastic agents in breast cancer: a systematic review and meta-analysisHeart Failure Reviews, 2023
- The effects of mesenchymal stem cell mitochondrial transplantation on doxorubicin‐mediated nephrotoxicity in ratsJournal of Biochemical and Molecular Toxicology, 2020
- The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced CardiotoxicityCardiovascular Drugs and Therapy, 2020
- Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in ratsCancer Chemotherapy and Pharmacology, 2020
- Exercise and Doxorubicin Treatment Modulate Cardiac Mitochondrial Quality Control SignalingCardiovascular Toxicology, 2017
- Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanismCellular and Molecular Life Sciences, 2016
- p66Shc signaling is involved in stress responses elicited by anthracycline treatment of rat cardiomyoblastsArchives of Toxicology, 2015
- Congestive heart failure in patients treated with doxorubicinCancer, 2003
- A Deletion of Mitochondrial DNA in Murine Doxorubicin-Induced CardiotoxicityBiochemical and Biophysical Research Communications, 1993